Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.

Banerjee SM, Williams NR, Davidson TI, El Sheikh S, Tran-Dang M, Davison S, Ghosh D, Keshtgar MR.

Eur J Surg Oncol. 2016 May;42(5):641-9. doi: 10.1016/j.ejso.2016.02.245. Epub 2016 Mar 2.

PMID:
26979647
2.

Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.

Banerjee SM, Michalopoulos NV, Williams NR, Davidson T, El Sheikh S, McDermott N, Tran-Dang MA, Davison S, Keshtgar MR.

Breast. 2014 Aug;23(4):378-84. doi: 10.1016/j.breast.2014.02.001. Epub 2014 Mar 12.

PMID:
24630617
3.

Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.

Espinosa-Bravo M, Sansano I, Pérez-Hoyos S, Ramos M, Sancho M, Xercavins J, Rubio IT, Peg V.

Eur J Surg Oncol. 2013 Jul;39(7):766-73. doi: 10.1016/j.ejso.2013.03.011. Epub 2013 Apr 19.

PMID:
23607911
4.

Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.

Mokhtar M, Tadokoro Y, Nakagawa M, Morimoto M, Takechi H, Kondo K, Tangoku A.

Breast Cancer. 2016 Mar;23(2):202-10. doi: 10.1007/s12282-014-0551-1. Epub 2014 Jul 29.

PMID:
25069434
5.

A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.

Babar M, Madani R, Thwaites L, Jackson PA, Devalia HL, Chakravorty A, Irvine TE, Layer GT, Kissin MW.

Eur J Surg Oncol. 2014 Mar;40(3):282-8. doi: 10.1016/j.ejso.2013.10.030. Epub 2013 Nov 21.

PMID:
24331309
6.

One-step nucleic acid amplification assay for intraoperative prediction of non-sentinel lymph node metastasis in breast cancer patients with sentinel lymph node metastasis.

Teramoto A, Shimazu K, Naoi Y, Shimomura A, Shimoda M, Kagara N, Maruyama N, Kim SJ, Yoshidome K, Tsujimoto M, Tamaki Y, Noguchi S.

Breast. 2014 Oct;23(5):579-85. doi: 10.1016/j.breast.2014.05.026. Epub 2014 Jun 25.

PMID:
24973902
7.

The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.

Chaudhry A, Williams S, Cook J, Jenkins M, Sohail M, Calder C, Winters ZE, Rayter Z.

Eur J Surg Oncol. 2014 Feb;40(2):150-7. doi: 10.1016/j.ejso.2013.12.007. Epub 2013 Dec 18.

PMID:
24378008
8.

Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.

Nabais C, Figueiredo J, Lopes P, Martins M, Araújo A.

Breast. 2017 Apr;32:33-36. doi: 10.1016/j.breast.2016.12.011. Epub 2016 Dec 25.

PMID:
28030783
9.

Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status.

Milner TD, de Lusignan S, Jones S, Jackson PA, Layer GT, Kissin MW, Irvine TE.

Breast. 2015 Oct;24(5):568-75. doi: 10.1016/j.breast.2015.05.004. Epub 2015 May 29.

PMID:
26032111
10.

One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.

Babar M, Madani R, Jackson P, Layer GT, Kissin MW, Irvine TE.

Surgeon. 2016 Apr;14(2):76-81. doi: 10.1016/j.surge.2014.06.001. Epub 2014 Nov 1.

PMID:
25444440
11.

Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.

Visser M, Jiwa M, Horstman A, Brink AA, Pol RP, van Diest P, Snijders PJ, Meijer CJ.

Int J Cancer. 2008 Jun 1;122(11):2562-7. doi: 10.1002/ijc.23451.

12.

Sentinel and nonsentinel lymph node assessment using a combination of one-step nucleic acid amplification and conventional histological examination.

Jimbo K, Kinoshita T, Suzuki J, Asaga S, Hojo T, Yoshida M, Tsuda H.

Breast. 2013 Dec;22(6):1194-9. doi: 10.1016/j.breast.2013.08.003. Epub 2013 Sep 14.

PMID:
24042046
13.

A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.

Huxley N, Jones-Hughes T, Coelho H, Snowsill T, Cooper C, Meng Y, Hyde C, Mújica-Mota R.

Health Technol Assess. 2015 Jan;19(2):v-xxv, 1-215. doi: 10.3310/hta19020. Review.

14.

Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.

Piñero-Madrona A, Ruiz-Merino G, Bernet L, Miguel-Martínez B, Vicente-García F, Viguri-Díaz MA, Giménez-Climent J.

Breast. 2014 Dec;23(6):859-64. doi: 10.1016/j.breast.2014.09.005. Epub 2014 Oct 3.

PMID:
25283682
15.

Intra-operative use of one-step nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymph nodes in breast cancer patients.

Heilmann T, Mathiak M, Hofmann J, Mundhenke C, van Mackelenbergh M, Alkatout I, Wenners A, Eckmann-Scholz C, Schem C.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1649-55. doi: 10.1007/s00432-013-1481-6. Epub 2013 Aug 2.

PMID:
23907595
16.

Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology.

Pathmanathan N, Renthawa J, French JR, Edstrom-Elder E, Hall G, Mahajan H, Teh C, Bilous MA.

ANZ J Surg. 2014 Oct;84(10):730-4. doi: 10.1111/ans.12668. Epub 2014 Jun 5.

PMID:
24899463
17.

Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.

Navarro-Cecilia J, Dueñas-Rodríguez B, Luque-López C, Ramírez-Expósito MJ, Martínez-Ferrol J, Ruíz-Mateas A, Ureña C, Carrera-González MP, Mayas MD, Martínez-Martos JM.

Eur J Surg Oncol. 2013 Aug;39(8):873-9. doi: 10.1016/j.ejso.2013.05.002. Epub 2013 May 25.

PMID:
23711734
18.

Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.

Vegué LB, Rojo F, Hardisson D, Iturriagagoitia AC, Panadés MJ, Velasco A, Bonet EL, Muñoz RC, Polo L; B-CLOSER-I Investigators.

Diagn Mol Pathol. 2012 Jun;21(2):69-76. doi: 10.1097/PDM.0b013e318241117b.

PMID:
22555089
19.

Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.

Peg V, Espinosa-Bravo M, Vieites B, Vilardell F, Antúnez JR, de Salas MS, Delgado-Sánchez JJ, Pinto W, Gozalbo F, Petit A, Sansano I, Del Mar Téllez M, Rubio IT.

Breast Cancer Res Treat. 2013 May;139(1):87-93. doi: 10.1007/s10549-013-2524-z. Epub 2013 Apr 11.

PMID:
23576079
20.

Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.

Osako T, Iwase T, Kimura K, Horii R, Akiyama F.

Eur J Cancer. 2013 Apr;49(6):1187-95. doi: 10.1016/j.ejca.2012.11.022. Epub 2012 Dec 19.

PMID:
23265708

Supplemental Content

Support Center